A comprehensive view of National Advisory Committee on Immunization. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
Canada's National Advisory Committee on Immunization offers guidance on use of protein-based Nuvaxovid XBB.1.5 COVID-19 vaccination, for individuals aged 12 and older
Published:
March 11, 2024
by Novavax Inc.
|
Ask us about our Government & Public Policy market view